$65 million to unlock the potential of personalised medicine through genomics

26 March 2019 - The Australian Government will provide over $65 million in competitive research grants to Australia’s best and brightest ...

Read more →

Are we being misled about precision medicine?

12 September 2018 - Doctors and hospitals love to talk about the cancer patients they’ve saved, and reporters love to write ...

Read more →

Scotland could be 'world leader' in precision medicine, says First Minister

9 September 2018 - Scotland has the potential to be a "world leader" in precision medicine, according to the first ...

Read more →

Comparison of two treatment models: precision medicine and preventive medicine

28 August 2018 - In an effort to improve the risk-benefit profile of therapies in clinical care, precision medicine seeks to ...

Read more →

Precision medicine success hinges on diagnostics' clinical utility

23 July 2018 - The companion diagnostic plays a significant role in precision medicine.  ...

Read more →

$50 million to provide life-saving support to cancer patients

18 July 2018 - The Australian Government will provide $50 million to support some of Australia’s sickest patients, battling the most ...

Read more →

Federal Government to announce $50 million custom cancer drug trial

17 July 2018 - Almost 600 Queenslanders will have their cancer’s DNA tested to identify the drugs that will keep ...

Read more →

Personalised medicine and pay for performance: should pharmaceutical firms be fully penalised when treatment fails?

17 June 2018 - In this article, we model the behaviour of a pharmaceutical firm that has marketing authorisation for a ...

Read more →

August 2018 PBAC special meeting - invitation for submissions open and background paper available

21 May 2018 - PD-1 and PD-L1 checkpoint inhibitor immunotherapies: options for subsidy consideration for multiple cancer types. ...

Read more →

Evolving landscape of US FDA drug approval in the era of precision oncology: finding the right balance between access and safety

15 May 2018 - Since 1992, the US FDA has implemented several programs for streamlined review and approval of agents that ...

Read more →

Precision medicines have faster approvals based on fewer and smaller trials than other medicines

7 May 2018 - Precision medicines can benefit patients by increasing the probability of a successful treatment response in selected patient ...

Read more →

Three steps toward a more sustainable path for targeted cancer drugs

18 April 2018 - Spending on cancer drugs in the United States has increased substantially over the past 5 years, ...

Read more →

Will personalised medicine mean higher costs for consumers?

1 March 2018 - Personalised medicine and treatments for rare diseases – many of which are extraordinarily expensive – are ...

Read more →

Transforming health care through precision medicine

31 January 2018 - Lately we've both been enjoying ITV's drama Victoria. By all accounts Queen Victoria lived well, dying ...

Read more →

Statement from FDA Commissioner on new FDA efforts to support more efficient development of targeted therapies

15 December 2017 - In recent years, the medical community has experienced a shift in the way health care is ...

Read more →